Use of SMOF lipid emulsion in very preterm infants does not affect the incidence of bronchopulmonary dysplasia-free survival.

Aissatou B K T NdiayeIbrahim MohamedEtienne PronovostGeorgina AngoaBruno PiedboeufBrigitte LemyreJehier AfifiMosarrat QureshiThibaut SérièsMireille GuillotDavid SimonyanKamran YusufPascal M LavoieWilliam D FraserBenoît MâsseAnne Monique NuytThierry Lacaze-MasmonteilIsabelle Marc

Published in: JPEN. Journal of parenteral and enteral nutrition (2022)

In very preterm infants, intravenous DHA-containing SMOF-LE during the neonatal period was not associated with BPD-free survival.

Keyphrases

free survival
preterm infants
low birth weight
fatty acid
risk factors
high dose
low dose